(Q28221437)

English

Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy

scientific article (publication date: March 2008)

In more languages

Statements

scholarly article

0 references

Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy (English)

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

Kandice Kottke-Marchant

2

object named as

Kandice Kottke-Marchant

0 references

author name string

Douglas J Christie

1

0 references

Robert T Gorman

3

0 references

language of work or name

0 references

publication date

March 2008

0 references

0 references

19

0 references

2

0 references

104-10

0 references

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

Antiplatelet effect of aspirin in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1080/09537100701504095

21 April 2017

Platelet function predicts myocardial damage in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Aspirin resistance: more than just a laboratory curiosity

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

The charisma of subgroups and the subgroups of CHARISMA

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

https://api.crossref.org/works/10.1080%2F09537100701504095

21 January 2018

Identifiers

10.1080/09537100701504095

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28221437&oldid=2153190793"